Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Top Cited Papers
Open Access
- 1 January 2014
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 25 (1), 91-101
- https://doi.org/10.1016/j.ccr.2013.12.015
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 MutationsThe New England Journal of Medicine, 2012
- Addiction to c-MYC in multiple myelomaBlood, 2012
- Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysisInternational Journal of Hematology, 2012
- BRAF L597 Mutations in Melanoma Are Associated with Sensitivity to MEK InhibitorsCancer Discovery, 2012
- Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myelomaBlood, 2012
- Clonal competition with alternating dominance in multiple myelomaBlood, 2012
- Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tidesBlood, 2012
- The Life History of 21 Breast CancersCell, 2012
- The clonal and mutational evolution spectrum of primary triple-negative breast cancersNature, 2012
- Clonal Architecture of Secondary Acute Myeloid LeukemiaThe New England Journal of Medicine, 2012